Jump to content

Psychotomimetism: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Wallabash (talk | contribs)
13 edits
m add a source about psychostimulants causing psychosis
m Fixed a PMC parameter in a citation. Please see Category:CS1 maint: PMC format.
Line 7: Line 7:
[[Carl Sagan]] used the word "psychotomimetic" in his anonymous article "Mr.X"<ref>{{cite web | title=Mr. X | url=http://marijuana-uses.com/mr-x/ | publisher=Marijuana-Uses.com | author=Sagan, Carl | access-date=November 8, 2012}}</ref> to describe the effects of [[cannabis (drug)|cannabis]], writing that "I smile, or sometimes even laugh out loud at the pictures on the insides of my eyelids. In this sense, I suppose cannabis is psychotomimetic, but I find none of the panic or terror that accompanies some psychoses."
[[Carl Sagan]] used the word "psychotomimetic" in his anonymous article "Mr.X"<ref>{{cite web | title=Mr. X | url=http://marijuana-uses.com/mr-x/ | publisher=Marijuana-Uses.com | author=Sagan, Carl | access-date=November 8, 2012}}</ref> to describe the effects of [[cannabis (drug)|cannabis]], writing that "I smile, or sometimes even laugh out loud at the pictures on the insides of my eyelids. In this sense, I suppose cannabis is psychotomimetic, but I find none of the panic or terror that accompanies some psychoses."


[[Stimulant|Psychostimulants]], such as [[cocaine]], [[Substituted amphetamine|amphetamines]], and [[Cathinone|synthetic cathinones]] (including [[bath salts (drug)|bath salts]]) are known to produce psychotic symptoms similar to paranoid [[schizophrenia]] and [[Bipolar disorder|manic-depressive psychosis]].<ref>{{Cite journal |last=Wearne |first=Travis A. |last2=Cornish |first2=Jennifer L. |date=2018-10-10 |title=A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology |url=https://www.frontiersin.org/article/10.3389/fpsyt.2018.00491/full |journal=Frontiers in Psychiatry |volume=9 |pages=491 |doi=10.3389/fpsyt.2018.00491 |issn=1664-0640 |pmc=PMC6191498 |pmid=30364176}}</ref>
[[Stimulant|Psychostimulants]], such as [[cocaine]], [[Substituted amphetamine|amphetamines]], and [[Cathinone|synthetic cathinones]] (including [[bath salts (drug)|bath salts]]) are known to produce psychotic symptoms similar to paranoid [[schizophrenia]] and [[Bipolar disorder|manic-depressive psychosis]].<ref>{{Cite journal |last=Wearne |first=Travis A. |last2=Cornish |first2=Jennifer L. |date=2018-10-10 |title=A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology |url=https://www.frontiersin.org/article/10.3389/fpsyt.2018.00491/full |journal=Frontiers in Psychiatry |volume=9 |pages=491 |doi=10.3389/fpsyt.2018.00491 |issn=1664-0640 |pmc=6191498 |pmid=30364176}}</ref>


[[Dissociative]] drugs (NMDA receptor antagonists) such as [[Phencyclidine|PCP]] also elicit psychotic behavior in its users which may result in medical intervention.
[[Dissociative]] drugs (NMDA receptor antagonists) such as [[Phencyclidine|PCP]] also elicit psychotic behavior in its users which may result in medical intervention.

Revision as of 21:12, 12 April 2023

A drug with psychotomimetic (also known as psychotogenic) actions mimics the symptoms of psychosis, including delusions and/or delirium, as opposed to only hallucinations. Psychotomimesis is the onset of psychotic symptoms following the administration of such a drug.

Some rarely used drugs of the opioid class have psychotomimetic effects. Particularly, mixed kappa receptor agonist mu receptor antagonist opioid analgesics can cause dose-related psychotomimesis.[1] This adverse effect, incidence 1–2%, limits their use. Pentazocine and butorphanol fall under this opioid class.[2]

There is evidence that cannabinoids are psychotomimetic,[3] especially delta-9-tetrahydrocannabinol (Δ9-THC). D'Souza et al. (2004) found that intravenous THC produced effects that resemble schizophrenia in both the positive symptoms (hallucinations, delusions, paranoia, and disorganized thinking) and negative symptoms (avolition, asociality, apathy, alogia, and anhedonia).[4] Certain strains of cannabis may be more psychotomimetic than others, probably due to the action of cannabidiol (CBD), which inhibits P450 3A11's metabolic conversion of THC to 11-Hydroxy-THC, which is four times more psychoactive.[5]p. 39

Carl Sagan used the word "psychotomimetic" in his anonymous article "Mr.X"[6] to describe the effects of cannabis, writing that "I smile, or sometimes even laugh out loud at the pictures on the insides of my eyelids. In this sense, I suppose cannabis is psychotomimetic, but I find none of the panic or terror that accompanies some psychoses."

Psychostimulants, such as cocaine, amphetamines, and synthetic cathinones (including bath salts) are known to produce psychotic symptoms similar to paranoid schizophrenia and manic-depressive psychosis.[7]

Dissociative drugs (NMDA receptor antagonists) such as PCP also elicit psychotic behavior in its users which may result in medical intervention.

Deliriant drugs (muscarinic acetylcholine receptor antagonists) such as BZ (QNB) also fall into the class of psychotomimetics.

List of psychotomimetic drugs

Substances that can induce psychotomimetic effects include:

See also

References

  1. ^ Pfeiffer (1986). "Psychotomimesis mediated by kappa opiate receptors". Science. 233 (4765): 774–776. Bibcode:1986Sci...233..774P. doi:10.1126/science.3016896. PMID 3016896. S2CID 37512800.
  2. ^ Musacchio JM (1990). "The psychotomimetic effects of opiates and the sigma receptor". Neuropsychopharmacology. 3 (3): 191–200. PMID 2163646.
  3. ^ Sewell R. A.; Ranganathan M.; D'Souza D. C. (2009). "Cannabinoids and psychosis". International Review of Psychiatry. 21 (2): 152–162. doi:10.1080/09540260902782802. PMID 19367509. S2CID 8221928.
  4. ^ D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH (2004). "The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis" (PDF). Neuropsychopharmacology. 29 (8): 1558–1572. doi:10.1038/sj.npp.1300496. PMID 15173844.
  5. ^ Brenneisen R. Chemistry and analysis of phytocannabinoids and other Cannabis constituents. In: ElSohly MA (ed). Marijuana and the cannabinoids. Humana Press Inc: Totowa, New Jersey, 2007.
  6. ^ Sagan, Carl. "Mr. X". Marijuana-Uses.com. Retrieved November 8, 2012.
  7. ^ Wearne, Travis A.; Cornish, Jennifer L. (2018-10-10). "A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology". Frontiers in Psychiatry. 9: 491. doi:10.3389/fpsyt.2018.00491. ISSN 1664-0640. PMC 6191498. PMID 30364176.{{cite journal}}: CS1 maint: unflagged free DOI (link)


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Psychotomimetism&oldid=1149538334"